Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Trans-synaptic (GABA-dopamine) modulation of cocaine induced dopamine release: A potential therapeutic strategy for cocaine abuse

Journal Article · · Journal of Nuclear Medicine
OSTI ID:441580
; ;  [1]
  1. Brookhaven National Laboratory, Upton, NY (United States); and others

We recently developed a new experimental strategy for measuring interactions between functionally-linked neurotransmitter systems in the primate and human brain with PET. As part of this research, we demonstrated that increases in endogenous GABA concentrations significantly reduced striatal dopamine concentrations in the primate brain. We report here the application of the neurotransmitter interaction paradigm with PET and with microdialysis to the investigation of a novel therapeutic strategy for treating cocaine abuse based on the ability of GABA to inhibit cocaine induced increases in striatal dopamine. Using gamma-vinyl GABA (GVG, a suicide inhibitor of GABA transaminase), we performed a series of PET studies where animals received a baseline PET scan with labeled raclopride injection, animals received cocaine (2.0 mg/kg). Normally, a cocaine challenge significantly reduces the striatal binding of {sup 11}C-raclopride. However, in animals pretreated with GVG, {sup 11}C-raclopride binding was less affected by a cocaine challenge compared to control studies. Furthermore, microdialysis studies in freely moving rats demonstrate that GVG (300 mg/kg) significantly inhibited cocaine-induced increases in extracellular dopamine release. GVG also attenuated cocaine-induced increases in locomotor activity. However, at a dose of 100 mg/kg, GVG had no effect. Similar findings were obtained with alcohol. Alcohol pretreatment dose dependantly (1-4 g/kg) inhibited cocaine-induced increases in extracellular dopamine concentrations in freely moving rats. Taken together, these studies suggest that therapeutic strategies targeted at increasing central GABA concentrations may be beneficial for the treatment of cocaine abuse.

OSTI ID:
441580
Report Number(s):
CONF-950603--
Journal Information:
Journal of Nuclear Medicine, Journal Name: Journal of Nuclear Medicine Journal Issue: Suppl.5 Vol. 36; ISSN 0161-5505; ISSN JNMEAQ
Country of Publication:
United States
Language:
English

Similar Records

Decreased striatal and enhanced thalamic dopaminergic responsivity in detoxified cocaine abusers
Journal Article · Thu May 01 00:00:00 EDT 1997 · Journal of Nuclear Medicine · OSTI ID:563333

Enhanced regional brain metabolic responses to benzodiazepines in cocaine abusers
Journal Article · Thu May 01 00:00:00 EDT 1997 · Journal of Nuclear Medicine · OSTI ID:563336

Methylphenidate attenuates limbic brain inhibition after cocaine-cues exposure in cocaine abusers.
Journal Article · Thu Jul 01 00:00:00 EDT 2010 · PLoS One · OSTI ID:1014312